This paper illustrates the application of Williams' design to bioequivalence trials. The replicated and variance-balanced crossover design is briefly outlined. Statistical methods for analysis of a Williams' design are discussed. Results are presented from a single dose/multiple doses study for assessment of bioequivalence.
WagnerJG. Biopharmaceutics and Relevant Pharmacokinetics. Hamilton, IL: Drug Intelligence Publication; 1971.
2.
ChowSCLiuJP. Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Marcel Dekker; 1992.
3.
LiuJP. Use of the repeated crossover designs in assessment of bioequivalence. Stat Med.1995.
4.
WilliamsEJ. Experimental designs balanced for the residual effects of treatment. Austral J Sci Res.1949;2:149–168.
5.
JonesBKenwardMG. Design and Analysis of Crossover Trials. London: Chapman-Hall; 1989.
6.
JohnPWM. Statistical Design and Analysis of Experiments. New York: Macmillan; 1971.
7.
GibaldiMPerrierD.Pharmacokinetics.2nd Edition. New York: Marcel Dekker; 1982.
8.
FarmenRHMuniakJFPittmanK.Management of pharmacokinetic data using HP-3357/main frame IBM interfacing. Drug Inf J.1987;21: 141.
9.
SchuirmannDJ. A comparison of the two onesided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmaco Biopharm.1987;15:657–680.
